Hormone therapy and breast cancer: risk communication and the ‘perfect storm’
Author:
Affiliation:
1. Division of Reproductive Endocrinology and Infertility, Queen’s University, Kingston, ON, Canada
Publisher
Informa UK Limited
Subject
Obstetrics and Gynaecology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13697137.2018.1527305
Reference33 articles.
1. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2. Shock, terror and controversy: how the media reacted to the Women's Health Initiative
3. Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
4. Have we come full circle – or moved forward? The Women's Health Initiative 10 years on
5. The evidence base for HRT: what can we believe?
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Menopausal hormone-replacement therapy and breast cancer risk: An updated and simplified view;Journal of Reproductive Healthcare and Medicine;2022-07-20
2. Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk;Climacteric;2022-02-11
3. Menopause Medicine: Past, Present, and Future;Journal of Obstetrics and Gynaecology Canada;2019-12
4. Traitement de la ménopause : passé, présent et futur;Journal of Obstetrics and Gynaecology Canada;2019-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3